Quick Answer
CytoDyn Inc. reported Operating Income of $9.66 million for fiscal year 2025.
CytoDyn Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $9.66M | +153.5% |
| 2024 | -$18.06M | +55.5% |
| 2023 | -$40.58M | +72.1% |
| 2022 | -$145.40M | -39.0% |
| 2021 | -$104.60M | -40.1% |
| 2020 | -$74.65M | -33.7% |
| 2019 | -$55.85M | -21.6% |
| 2018 | -$45.92M | -68.0% |
| 2017 | -$27.33M | -29.1% |
| 2016 | -$21.18M | -8.1% |
| 2015 | -$19.60M | -141.6% |
| 2014 | -$8.11M | -1.5% |
| 2013 | -$7.99M | -7.2% |
| 2012 | -$7.46M | -101.6% |
| 2011 | -$3.70M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$21.69M | -485.1% | -338.6% |
| August 31, 2025 | -$4.95M | -122.0% | -23.5% |
| February 28, 2025 | -$4.00M | -17.3% | -8.0% |
| November 30, 2024 | -$3.71M | -9.1% | -116.5% |
| August 31, 2024 | $22.44M | +586.5% | +757.2% |
| February 29, 2024 | -$3.41M | +12.9% | -0.5% |
| November 30, 2023 | -$3.40M | +85.3% | +26.3% |
| August 31, 2023 | -$4.61M | +52.5% | -17.6% |
- CytoDyn Inc. showed an increase of +153.5% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, CytoDyn Inc.’s operating income has grown by 361.2% (from -$3.70 million to $9.66 million).
- The most recent figure is from CytoDyn Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: